Patents matching “The United States of America”

US 8283370

Imidazolidinedione derivatives as antimalarial agents, preparation thereof, and methods of use

The United States of America as represented by the Secretary of the Army · Granted Oct 9, 2012 · Expires Oct 4, 2032

US 8278246

Biocontrol of storage maladies of potatoes by bacterial antagonists produced in co-culture

The United States of America, as represented by the Secretary of Agriculture · Granted Oct 2, 2012 · Expires Sep 27, 2032

US 8278272

GLP-1, exendin-4, peptide analogs and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 2, 2012 · Expires Sep 27, 2032

US 8278083

Inactivated influenza virus compositions

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 2, 2012 · Expires Sep 27, 2032

US 8278458

Desferrithiocin polyether analogues

The United States of America, as represented by the Department of Health and Human Services · Granted Oct 2, 2012 · Expires Sep 27, 2032

US 8278100

Lasonolide compounds as reagents for inducing premature chromosome condensation and methods for treating disorders

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 2, 2012 · Expires Sep 27, 2032

US 8278348

Chondropsin-class antitumor V-atpase inhibitor compounds, compositions and methods of use thereof

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 2, 2012 · Expires Sep 27, 2032

US 8273724

Melanoma antigens and their use in diagnostic and therapeutic methods

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 25, 2012 · Expires Sep 20, 2032

US 8273797

Treating renal cancer using 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-2-methyl-benzaldehyde

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 25, 2012 · Expires Sep 20, 2032

US 8268890

Method of treating ischemia/reperfusion injury with nitroxyl donors

The United States of America, as represented by the Secretary, Health and Human Services · Granted Sep 18, 2012 · Expires Sep 13, 2032

US 8268323

Conformationally stabilized HIV envelope immunogens

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 18, 2012 · Expires Sep 13, 2032

US 8268602

Cellular and viral inactivation

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 18, 2012 · Expires Sep 13, 2032

US 8268615

Expression, purification and uses of a plasmodium falciparum liver stage antigen 1 polypeptide

The United States of America as represented by the Secretary of the Army · Granted Sep 18, 2012 · Expires Sep 13, 2032

US 8268894

Compositions and methods for the treatment of infectious diseases

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 18, 2012 · Expires Sep 13, 2032

US 8263091

Method of treating and preventing infections in immunocompromised subjects with immunostimulatory CpG oligonucleotides

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 11, 2012 · Expires Sep 6, 2032

US 8263759

Sets of probes and primers for the diagnosis of select cancers

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 11, 2012 · Expires Sep 6, 2032

US 8258280

Plasmodium vivax hybrid circumsporozoite protein and vaccine

The United States of America as represented by the Secretary of the Army · Granted Sep 4, 2012 · Expires Aug 30, 2032

US 8257915

Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 4, 2012 · Expires Aug 30, 2032

US 8258106

Immunostimulatory nucleic acid molecules

The United States of America, as represented by the Department of Health and Human Services · Granted Sep 4, 2012 · Expires Aug 30, 2032

US 8258278

Methods and compositions for the treatment and prevention of cancer

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 4, 2012 · Expires Aug 30, 2032

US 8252545

Peptides of a melanoma antigen and their use in diagnostic, prophylactic, and therapeutic methods

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 28, 2012 · Expires Aug 23, 2032

US 8252538

MicroRNA expression signature for predicting survival and metastases in hepatocellular carcinoma

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Aug 28, 2012 · Expires Aug 23, 2032

US 8252550

Targeting poly-γ-glutamic acid to treat Staphylococcus epidermidis and related infections

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Aug 28, 2012 · Expires Aug 23, 2032

US 8252845

Pterostilbene as an agonist for the peroxisome proliferator-activated receptor alpha isoform

The United States of America, as represented by the Secretary of Agriculture · Granted Aug 28, 2012 · Expires Aug 23, 2032